Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT ID: NCT06858878

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

1105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-17

Study Completion Date

2027-04-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Type 2 Diabetes Mellitus T2DM Obesity Overweight Maridebart Cafraglutide AMG 133 MariTide Chronic Weight Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maridebart Cafraglutide High Dose

Participants will receive maridebart cafraglutide high dose subcutaneously (SC) for 72 weeks.

Group Type EXPERIMENTAL

Maridebart cafraglutide

Intervention Type DRUG

Maridebart cafraglutide will be adminstered SC.

Maridebart Cafraglutide Medium Dose

Participants will receive maridebart cafraglutide medium dose SC for 72 weeks.

Group Type EXPERIMENTAL

Maridebart cafraglutide

Intervention Type DRUG

Maridebart cafraglutide will be adminstered SC.

Maridebart Cafraglutide Low Dose

Participants will receive maridebart cafraglutide low dose SC for 72 weeks.

Group Type EXPERIMENTAL

Maridebart cafraglutide

Intervention Type DRUG

Maridebart cafraglutide will be adminstered SC.

Placebo

Participants will receive placebo SC for 72 weeks.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo will be adminstered SC.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maridebart cafraglutide

Maridebart cafraglutide will be adminstered SC.

Intervention Type DRUG

Placebo

Placebo will be adminstered SC.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AMG 133 MariTide

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years.
* Body mass index ≥ 27 kg/m\^2.
* History of at least 1 self-reported unsuccessful attempt at weight loss by diet and exercise.
* Diagnosis of T2DM.

Exclusion Criteria

* Type 1 diabetes mellitus.
* Self-reported change in body weight \> 5 kg within 90 days before screening.
* Proliferative diabetic retinopathy OR diabetic macular edema OR non-proliferative diabetic retinopathy that requires acute treatment.
* Obesity induced by other endocrinologic disorders.
* Family (first-degree relative\[s\]) or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2.
* History of chronic pancreatitis or history of acute pancreatitis within 180 days before screening.
* History of unstable major depressive disorder (MDD) or other severe psychiatric disorder within 2 years before screening.
* Lifetime history of suicide attempt.
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alliance for Multispecialty Research Mobile

Mobile, Alabama, United States

Site Status

Gilbert Center for Family Medicine

Gilbert, Arizona, United States

Site Status

Desert Clinical Research

Mesa, Arizona, United States

Site Status

Avacare Foothills Research Center

Phoenix, Arizona, United States

Site Status

San Fernando Valley Health Institute

Canoga Park, California, United States

Site Status

Core Healthcare Group

Cerritos, California, United States

Site Status

Velocity Clinical Research Chula Vista

Chula Vista, California, United States

Site Status

Headlands Research California

Escondido, California, United States

Site Status

Paradigm Clinical Research

Modesto, California, United States

Site Status

Flourish Research

Northridge, California, United States

Site Status

University of California Irvine

Orange, California, United States

Site Status

Empire Clinical Research

Pomona, California, United States

Site Status

Infinity Clinical Trials

San Diego, California, United States

Site Status

Greenwich Clinical Trials

Riverside, Connecticut, United States

Site Status

Indago Research and Health Center

Hialeah, Florida, United States

Site Status

Optimus U Corporation

Miami, Florida, United States

Site Status

New Horizon Research Center

Miami, Florida, United States

Site Status

San Marcus Research Clinic Inc

Miami Lakes, Florida, United States

Site Status

Florida Institute for Clinical Research

Orlando, Florida, United States

Site Status

Encore Medical Research of Weston LLC

Weston, Florida, United States

Site Status

Conquest Research - Winter Park

Winter Park, Florida, United States

Site Status

Alliance For Multispecialty Research - Oak Brook

Oak Brook, Illinois, United States

Site Status

Alliance for Multispecialty Research, LLC - Park Ridge

Park Ridge, Illinois, United States

Site Status

Endeavor Health Medical Group - Endocrinology and Diabetes- Skokie

Skokie, Illinois, United States

Site Status

Indiana Medical Research Institute

Merrillville, Indiana, United States

Site Status

Iowa Diabetes Research

West Des Moines, Iowa, United States

Site Status

Alliance for Multispecialty Research Newton

Newton, Kansas, United States

Site Status

Alliance for Multispecialty Research LLC

Wichita, Kansas, United States

Site Status

Advanced Internal Medicine

Paducah, Kentucky, United States

Site Status

Ima Clinical Research- Monroe

Monroe, Louisiana, United States

Site Status

Annapolis Internal Medicine, LLC

Annapolis, Maryland, United States

Site Status

Brigham and Womens Hospital

Boston, Massachusetts, United States

Site Status

International Diabetes Center - HealthPartners Institute

Minneapolis, Minnesota, United States

Site Status

Alliance for Multispecialty Research - Kansas City

Kansas City, Missouri, United States

Site Status

Palm Research Center Inc

Las Vegas, Nevada, United States

Site Status

Vector Clinical Trials

Sparks, Nevada, United States

Site Status

Premier Research

Trenton, New Jersey, United States

Site Status

Albany Medical College

Albany, New York, United States

Site Status

Asheville Clinical Research

Asheville, North Carolina, United States

Site Status

Physicians East

Greenville, North Carolina, United States

Site Status

Carteret Medical Group

Morehead City, North Carolina, United States

Site Status

West Clinical Research

Morehead City, North Carolina, United States

Site Status

Velocity Clinical Research - Cincinnati

Blue Ash, Ohio, United States

Site Status

Velocity Clinical Research - Springdale

Cincinnati, Ohio, United States

Site Status

Velocity Clinical Research - Providence

East Greenwich, Rhode Island, United States

Site Status

Medical Care LLC

Elizabethton, Tennessee, United States

Site Status

Elligo Clinical Research Center

Austin, Texas, United States

Site Status

Osvaldo A Brusco MD PA

Corpus Christi, Texas, United States

Site Status

Cedar Health Research, LLC

Dallas, Texas, United States

Site Status

Soma Clinical Trials, LLC

Denison, Texas, United States

Site Status

Cedar Health Research, LLC

Euless, Texas, United States

Site Status

Juno Research LLC

Houston, Texas, United States

Site Status

Juno Research LLC

Houston, Texas, United States

Site Status

Tekton Research

McKinney, Texas, United States

Site Status

Northeast Clinical Research of San Antonio LLC

San Antonio, Texas, United States

Site Status

Alliance for Multispecialty Research - Layton

Layton, Utah, United States

Site Status

Manassas Clinical Research Center Inc

Manassas, Virginia, United States

Site Status

VA Puget Sound Healthcare System

Seattle, Washington, United States

Site Status

Ima Clinical Research - West Virginia

Morgantown, West Virginia, United States

Site Status

Centro Medico Viamonte

CABA, Buenos Aires, Argentina

Site Status

Cedic Centro de Investigacion Clinica

CABA, Buenos Aires, Argentina

Site Status

Cemedic Centro de Especialidades Medicas

CABA, Buenos Aires, Argentina

Site Status

Maffei Centro Medico

CABA, Buenos Aires, Argentina

Site Status

Consultorios Medicos Dr Besada

CABA, Buenos Aires, Argentina

Site Status

Cinme - Centro de Investigaciones Metabolicas

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status

Ciprec Centro de Investigacion y Prevencion Cardiovascular

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status

Ambulatory for specialized outpatient medical aid in endocrinology-Dr Albena Dinkova EOOD

Pleven, , Bulgaria

Site Status

Diagnostic - Consultative Center XX - Sofia EOOD

Sofia, , Bulgaria

Site Status

Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda EAD

Sofia, , Bulgaria

Site Status

University Multiprofile Hospital for Active Treatment Sofiamed OOD

Sofia, , Bulgaria

Site Status

Prevencia-2000-Medical center for outpatient medical aid OOD

Stara Zagora, , Bulgaria

Site Status

Medical Center Berbatov EOOD

Yambol, , Bulgaria

Site Status

tlc Diabetes and Endocrinology

Surrey, British Columbia, Canada

Site Status

Chronic Disease Innovation Centre

Winnipeg, Manitoba, Canada

Site Status

Nova Scotia Health Authority, Queen Elizabeth ii Health Sciences Centre

Halifax, Nova Scotia, Canada

Site Status

Centricity Research Brampton

Brampton, Ontario, Canada

Site Status

Aggarwal and Associates Ltd

Brampton, Ontario, Canada

Site Status

Centricity Research Vaughan

Concord, Ontario, Canada

Site Status

Winterberry Family Medicine

Hamilton, Ontario, Canada

Site Status

Premier Clinical Trial Network

Hamilton, Ontario, Canada

Site Status

Milestone Research

London, Ontario, Canada

Site Status

Centricity Research Ottawa LMC

Nepean, Ontario, Canada

Site Status

Your Research Network Inc.

Niagara Falls, Ontario, Canada

Site Status

North York Diagnostic and Cardiac Centre

North York, Ontario, Canada

Site Status

Bluewater Clinical Research Group Incorporated

Sarnia, Ontario, Canada

Site Status

Albion Finch Medical Centre

Toronto, Ontario, Canada

Site Status

Centricity Research Quebec City

Lévis, Quebec, Canada

Site Status

Institut de recherches cliniques de Montreal

Montreal, Quebec, Canada

Site Status

Centre Medical Acadie

Montreal, Quebec, Canada

Site Status

Centricity Research Pointe-Claire

Pointe-Claire, Quebec, Canada

Site Status

Diex Recherche Trois Rivieres

Trois-Rivières, Quebec, Canada

Site Status

Fakultni nemocnice Brno

Brno, , Czechia

Site Status

CCR Ostrava sro

Ostrava, , Czechia

Site Status

Diahelp sro

Pardubice, , Czechia

Site Status

Pratia Pardubice as

Pardubice, , Czechia

Site Status

Fakultni nemocnice Kralovske Vinohrady

Prague, , Czechia

Site Status

Vseobecna fakultni nemocnice v Praze

Prague, , Czechia

Site Status

Institut klinicke a experimentalni mediciny

Prague, , Czechia

Site Status

Milan Kvapil sro

Prague, , Czechia

Site Status

Restrial sro

Prague, , Czechia

Site Status

Endokrinologie Cerny Most sro

Prague, , Czechia

Site Status

Milan Kvapil sro

Pribram VIII, , Czechia

Site Status

Universitatsklinikum Aachen

Aachen, , Germany

Site Status

Universitaets-Herzzentrum Freiburg - Bad Krozingen

Bad Krozingen, , Germany

Site Status

Diabetespraxis Bad Mergentheim

Bad Mergentheim, , Germany

Site Status

Universitaetsklinikum der Ruhr-Universitaet Bochum

Bad Oeynhausen, , Germany

Site Status

Charite - Universitaetsmedizin Berlin, Campus Mitte

Berlin, , Germany

Site Status

Velocity Clinical Research GmbH

Berlin, , Germany

Site Status

Diabetespraxis Dr. Hermann Braun

Berlin, , Germany

Site Status

Mvz am Bahnhof Spandau

Berlin, , Germany

Site Status

Zentrum fuer Klinische Studien Suedbrandenburg GmbH

Elsterwerda, , Germany

Site Status

InnoDiab Forschung

Essen, , Germany

Site Status

Schwerpunktpraxis fuer Diabetes, Gefaess- & Ernaehrungsmedizin

Falkensee, , Germany

Site Status

Diabeteszentrum Hamburg West

Hamburg, , Germany

Site Status

Endokrinologikum Hamburg

Hamburg, , Germany

Site Status

Diabetologische Schwerpunktpraxis Hohenmoelsen

Hohenmölsen, , Germany

Site Status

Universitaetsklinikum Leipzig

Leipzig, , Germany

Site Status

AmBeNet GmbH

Leipzig, , Germany

Site Status

Kardiologische Praxis Doktor Jens Taggeselle

Markkleeberg, , Germany

Site Status

Centrum für Diagnostik und Gesundheit

München, , Germany

Site Status

Zentrum fuer Diabtes und Gefaesskrankheiten im Franziskus Carré Muenster

Münster, , Germany

Site Status

Red-Institut GmbH

Oldenburg, , Germany

Site Status

Lausmed Kft

Baja, , Hungary

Site Status

DRC Gyogyszervizsgalo Kozpont Kft

Balatonfüred, , Hungary

Site Status

Clinexpert Kft

Budapest, , Hungary

Site Status

Obudai Egeszsegugyi Centrum Kft

Budapest, , Hungary

Site Status

ClinDiab Kft

Budapest, , Hungary

Site Status

MED-TIMA Kft

Budapest, , Hungary

Site Status

Borvo Clinic Kft

Debrecen, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Komaromi Selye Janos Korhaz

Komárom, , Hungary

Site Status

Borbanya Praxis Egeszsegugyi Kft

Nyíregyháza, , Hungary

Site Status

Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz

Szombathely, , Hungary

Site Status

IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico di Sant Orsola

Bologna, , Italy

Site Status

Universita degli Studi Gabriele D Annunzio di Chieti e Pescara

Chieti, , Italy

Site Status

Azienda Ospedaliero Universitaria Careggi

Florence, , Italy

Site Status

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Milan, , Italy

Site Status

IRCCS Centro Cardiologico Monzino

Milan, , Italy

Site Status

Azienda Socio Sanitaria Territoriale Fatebenefratelli Sacco

Milan, , Italy

Site Status

Ospedale Civico, Di Cristina e Benfratelli

Palermo, , Italy

Site Status

Mikannohana Clinic, Diabetes, Endocrinology and Metabolism

Matsuyama, Ehime, Japan

Site Status

Morizono Medical Clinic

Kitakyusyu-shi, Fukuoka, Japan

Site Status

Mazda Hospital of Mazda Motor Corporation

Aki-gun, Hiroshima, Japan

Site Status

Nakamoto Medical Clinic

Mito, Ibaraki, Japan

Site Status

Nakakinen Clinic

Naka, Ibaraki, Japan

Site Status

Ohishi Naika Clinic

Tsuchiura-shi, Ibaraki, Japan

Site Status

Morinaga Ueno Clinic

Kumamoto, Kumamoto, Japan

Site Status

Shiraiwa Medical Clinic

Kashiwara-shi, Osaka, Japan

Site Status

Suruga Clinic

Shizuoka, Shizuoka, Japan

Site Status

Yutenji Medical Clinic

Meguro-ku, Tokyo, Japan

Site Status

Medical Corporation Ouitsukai Kanno Naika

Mitaka-shi, Tokyo, Japan

Site Status

Salvia-Lekston i Madej Spolka Jawna

Katowice, , Poland

Site Status

Centrum Terapii Wspolczesnej J M Jasnorzewska Spolka Komandytowo Akcyjna

Lodz, , Poland

Site Status

Clinical Best Solutions Sp zoo Spolka Komandytowa Gabinet Lekarski

Lublin, , Poland

Site Status

Ekamed Spolka z Ograniczona Odpowiedzialnoscia

Lublin, , Poland

Site Status

Medicome Spolka z Ograniczona Odpowiedzialnoscia

Oświęcim, , Poland

Site Status

Velocity Nova Sp zoo Velocity Pulawy

Puławy, , Poland

Site Status

NZOZ Przychodnia Specjalistyczna A Wittek H Rudzki spolka jawna

Ruda Śląska, , Poland

Site Status

Velocity Nova Sp zoo Velocity Staszow

Staszów, , Poland

Site Status

Tomasz Blicharski Lubelskie Centrum Diagnostyczne

Świdnik, , Poland

Site Status

Nbr Polska Tomasz Klodawski

Warsaw, , Poland

Site Status

Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji

Warsaw, , Poland

Site Status

Wromedica I Bielicka A Strzalkowska SC

Wroclaw, , Poland

Site Status

Latin Clinical Trial Center

San Juan, , Puerto Rico

Site Status

Korea University Ansan Hospital

Ansan-si, Gyeonggi-do, , South Korea

Site Status

Yeungnam University Medical Center

Daegu, , South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, , South Korea

Site Status

Korea University Anam Hospital

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Severance Hospital Yonsei University Health System

Seoul, , South Korea

Site Status

KyungHee University Gangdong Hospital

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

The Catholic University of Korea Seoul St Marys Hospital

Seoul, , South Korea

Site Status

Hallym University Kangnam Sacred Heart Hospital

Seoul, , South Korea

Site Status

Yonsei University Wonju Severance Christian Hospital

Wonju-si, Gangwon-do, , South Korea

Site Status

Ormeau Clinical Trials Ltd

Belfast, , United Kingdom

Site Status

FutureMeds Birmingham

Birmingham, , United Kingdom

Site Status

Layton Medical Centre

Blackpool, , United Kingdom

Site Status

Waterloo Medical Centre

Blackpool, , United Kingdom

Site Status

Southmead Hospital

Bristol, , United Kingdom

Site Status

Staploe Medical Centre

Ely, , United Kingdom

Site Status

FutureMeds Glasgow

Glasgow, , United Kingdom

Site Status

Hull Royal Infirmary

Hull, , United Kingdom

Site Status

NIHR Leicestershire & Northamptonshire Commercial Research Delivery Centre

Leicester, , United Kingdom

Site Status

Aintree University Hospital

Liverpool, , United Kingdom

Site Status

Clifton Medical Centre

Rotherham, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Bulgaria Canada Czechia Germany Hungary Italy Japan Poland Puerto Rico South Korea United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20210184

Identifier Type: -

Identifier Source: org_study_id